Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Aperture Venture Partners

Founders Eric H. Sillman

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 60
Average round size
info
The average size of a deal this fund participated in
$36M
Portfolio companies 37
Rounds per year 2.73
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits 22
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Therapeutics
Summary

Aperture Venture Partners appeared to be the VC, which was created in 2002. The venture was found in North America in United States. The main department of described VC is located in the New York.

This organization was formed by Eric H. Sillman. Besides them, we counted 3 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Aperture Venture Partners, startups are often financed by Lumira Ventures, TPG Biotech, Vivo Capital. The meaningful sponsors for the fund in investment in the same round are Third Point Ventures, Vivo Capital, Lumira Ventures. In the next rounds fund is usually obtained by Third Point Ventures, OrbiMed, Ziegler Meditech Equity Partners.

Opposing the other organizations, this Aperture Venture Partners works on 17 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2015. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity.

The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight MAKO Surgical, Cardiac Dimensions, Channel Medsystems. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Food and Beverage, Therapeutics.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Aperture Venture Partners:
Typical Co-investors
Aperture Venture Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Aperture Venture Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ShiraTronics

Clinical Trials
Health Care
Medical Device
30 Sep 2024 Minneapolis, Minnesota, United States

XII Medical

Health Care
Medical Device
Wellness
$45M21 Aug 2024 Union City, California, United States

Miach Orthopaedics

Biotechnology
Health Care
Manufacturing
Medical
Medical Device
Wellness
$20M02 Apr 2024 Boston, Massachusetts, United States

XII Medical

Health Care
Medical Device
Wellness
$30M05 May 2022 Union City, California, United States

V-Wave

Biotechnology
Health Care
Medical
Medical Device
$98M16 Dec 2021 Israel, North District, Israel

PetDx

Bioinformatics
Biotechnology
Genetics
Health Diagnostics
Life Science
Pet
$62M09 Dec 2021 San Diego, California, United States

Cortica

Health Care
Hospital
Therapeutics
$60M29 Jun 2021 San Diego, California, United States

Neuros Medical

Health Care
Life Science
Medical
Medical Device
Therapeutics
$38M07 Jan 2021 Ohio, United States

Cardiac Dimensions

Biotechnology
Health Care
Medical Device
$17M29 Sep 2020 Washington, United States
News
Cortica Raises $60M in Series C Funding

– Cortica from San Diego CA is focused on clinical services for autism and other neurodevelopmental conditions.
– Series C $60m funding round was led by Longitude Capital with participation from 406 Ventures, Adam Boehler, Questa Capital and Aperture Venture Partners and Silicon Valley Bank.
– The new financing will be used to accelerate growth, expand centers across multiple states, and investigate novel drug, device, and diagnostic technologies through sponsored and NIH-funded research.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Aperture Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 60
Average round size 36M
Rounds per year 2.73
Peak activity year 2015
Lead investments 4
Follow on index 0.38
Exits 22
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ShiraTronics

Clinical Trials
Health Care
Medical Device
30 Sep 2024 Minneapolis, Minnesota, United States

XII Medical

Health Care
Medical Device
Wellness
$45M21 Aug 2024 Union City, California, United States

Miach Orthopaedics

Biotechnology
Health Care
Manufacturing
Medical
Medical Device
Wellness
$20M02 Apr 2024 Boston, Massachusetts, United States

XII Medical

Health Care
Medical Device
Wellness
$30M05 May 2022 Union City, California, United States

V-Wave

Biotechnology
Health Care
Medical
Medical Device
$98M16 Dec 2021 Israel, North District, Israel

PetDx

Bioinformatics
Biotechnology
Genetics
Health Diagnostics
Life Science
Pet
$62M09 Dec 2021 San Diego, California, United States

Cortica

Health Care
Hospital
Therapeutics
$60M29 Jun 2021 San Diego, California, United States

Neuros Medical

Health Care
Life Science
Medical
Medical Device
Therapeutics
$38M07 Jan 2021 Ohio, United States

Cardiac Dimensions

Biotechnology
Health Care
Medical Device
$17M29 Sep 2020 Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: